drugset / Trial / NCT07400536
A Clinical Study on the Treatment of LACC With Cadonilimab Combined With Chemotherapy Followed by CCRT
Phase 3
Recruiting
378 enrolled
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Akesobio · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
This study mainly evaluated the efficacy and safety of Cadonilimab combined with chemotherapy followed by concurrent chemoradiotherapy versus standard concurrent chemoradiotherapy in the treatment of locally advanced cervical cancer.
Timeline
- Start
- 2026-04-24
- Primary completion
- 2028-07-18
- Completion
- 2032-07-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Albumin paclitaxel | Unknown | 90 mg/m2 | — |
| Subject | Cadonilimab | Monoclonal antibody | — | — |
| Subject | Cisplatin | Other / unclassified | 25 mg/m2 | — |
| Subject | Cisplatin | Other / unclassified | 40 mg/m2 | — |